Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Int... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Platelet-Rich Plasma with Hyaluronic Acid Injections for Post- Viral Olfactory loss. A double-blin... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Leveraging AS01-induced immune cell reprogramming to modulate immune dysregulation in rheumatoid a... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778979) titled 'Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas' on Aug. 18. Bri... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II open label study of DJI136, a DLL3-targeted CAR-T therapy, in adult patients with ES-... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Beamion PANTUMOR 1: A Phase II, multicentre, multicohort, open-label trial to evaluate the efficac... Read More
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'An open-label, multi-center, phase I/Ib study of IEV407 as a single agent and in combination with ... Read More
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779954) titled 'Nordic Sperm DNA Study' on Aug. 13. Brief Summary: Introduction The goal of this prospect... Read More